Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Glaukos Corporation

Glaukos Corporation (GKOS) Stock Overview

Explore Glaukos Corporation’s financial performance, market position, analyst ratings, and future outlook.

GKOS●NYSE
HealthcareMedical - Devices
$189.45
$2.82(1.51%)
U.S. Market opens in 3h 6m

Glaukos Corporation (GKOS)

Meyka AI Score

Z

Key Financials

Market Cap11.2B
P/E Ratio-58.22
EPS (TTM)$-0.86
ROE-0.27%
Fundamental Analysis

AI Price Forecasts

1 Month$174.55
3 Months$145.05
1 Year Target$145.86

GKOS Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Glaukos Corporation (NYSE: GKOS) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Glaukos Corporation's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of GKOS on the NYSE shows an RSI of 84.50, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $145.86 for the NYSE listing.

Key metrics behind Glaukos Corporation's NYSE-traded stock include a P/E ratio of -58.22 and a market capitalization of 11.2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of GKOS on the NYSE.

Price Performance (NYSE: GKOS)

1-Day Change
1.52%
5-Day Change
9.55%
1-Month Change
24.06%
3-Month Change
38.00%
6-Month Change
73.07%
Year-to-Date (YTD) Change
67.80%
1-Year Change
106.41%
3-Year Change
156.69%
5-Year Change
286.97%
All-Time (Max) Change
506.85%

Contact Information

https://www.glaukos.com
949 367 9600
One Glaukos Way, Aliso Viejo, CA, 92656

Company Facts

10,940 Employees
IPO DateJun 25, 2015
CountryUS
Actively Trading

Frequently Asked Questions